Evidence map›Paper›PMID 35361887›Full record

ArticleJournal of perinatology : official journal of the California Perinatal Association2022

Does active treatment in infants born at 22-23 weeks correlate with outcomes of more mature infants at the same hospital? An analysis of California NICU data, 2015-2019.

Shalmali Bane, Matthew A Rysavy, Suzan L Carmichael, Tianyao Lu, Mihoko Bennett, Henry C Lee

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of perinatology : official journal of the California Perinatal Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Shalmali BaneDepartment of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, 94306, USA. sbane@stanford.edu.ORCID 0000-0002-4074-3437
Matthew A RysavyDepartment of Pediatrics, McGovern Medical School, University of Texas Health Science Center, Houston, TX, 77030, USA.ORCID 0000-0002-1209-6607
Suzan L CarmichaelDepartment of Pediatrics, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Tianyao LuDepartment of Pediatrics, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Mihoko BennettDepartment of Pediatrics, Stanford University School of Medicine, Stanford, CA, 94305, USA.ORCID 0000-0002-3449-9538
Henry C LeeDepartment of Pediatrics, Stanford University School of Medicine, Stanford, CA, 94305, USA.ORCID 0000-0001-8383-1720
California Perinatal Quality Care Collaborative · GBStanford Health Care · USStanford Medicine · USThe University of Texas Health Science Center at Houston · US

Funding

Improving outcomes of periviable births via an enhanced prediction toolR01HD098287 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LEE, HENRY CHONG · 2020 to 2024
$1.7M
NICHD NIH HHS R01 HD098287
6 · The paper itself

Abstract

objectiveTo investigate whether hospital rates of active treatment for infants born at 22-23 weeks is associated with survival of infants born at 24-27 weeks. STUDY

designWe included all liveborn infants 22-27 weeks of gestation delivered at California Perinatal Quality Care Collaborative hospitals from 2015 to 2019. We assessed (1) the correlation of active treatment (e.g., endotracheal intubation, epinephrine) in 22-23 week infants and survival until discharge for 24-27 week infants and (2) the association of active treatment with survival using multilevel models.

resultThe 22-23 week active treatment rate was associated with infant outcomes at 22-23 weeks but not 24-27 weeks. A 10% increase in active treatment did not relate to 24-25 week (adjusted OR: 1.00 [95% CI: 0.95-1.05]), or 26-27 week survival (aOR: 1.02 [0.95-1.09]).

conclusionThe hospital rate of active treatment for infants born at 22-23 weeks was not associated with improved survival for 24-27 week infants.

Indexed as

Infant MortalityIntensive Care Units, NeonatalEpinephrineFemaleGestational AgeHospitalsHumansInfantInfant, NewbornIntubation, IntratrachealPregnancyEpinephrine

Identifiers

PMID35361887
PMCPMC9522931
OpenAlexW4220936634

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.